Manipulating dendritic cell biology for the active immunotherapy of cancer.
about
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinomaLow doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patientsDendritic Cells: A Double-Edged Sword in Immune Responses during Chagas DiseaseSpecific medicinal plant polysaccharides effectively enhance the potency of a DC-based vaccine against mouse mammary tumor metastasisImmunosuppressive networks in the tumour environment and their therapeutic relevanceImmunosuppressive strategies that are mediated by tumor cellsMultidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma.CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells.Activation of tolerogenic dendritic cells in the tumor draining lymph nodes by CD8+ T cells engineered to express CD40 ligand.FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapyGeneration of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28Improved efficacy of dendritic cell-based immunotherapy by cutaneous laser illumination.Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA.Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patientsEx vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantationEnhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression.In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide(89)Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based TherapiesPhenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors.Reduced tumourigenicity of EG7 after RANTES gene transfer and the underlying mechanism.Dendritic cell generation and CD4+ CD25high FOXP3+ regulatory t cells in human head and neck carcinoma during radio-chemotherapy.Antigen presenting cells in the skin of a patient with hair loss and systemic lupus erythematosusImmune restoration following hematopoietic stem cell transplantation: an evolving target.Dendritic cells in atherosclerosis: current status of the problem and clinical relevance.Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens.Dendritic cell fusion vaccines for cancer immunotherapy.MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells.Tumor vaccines for breast cancerCombining radiotherapy and immunotherapy: a revived partnership.Primary cutaneous B-cell lymphomas: then and now.Treatment of pulmonary metastatic tumors in mice using lentiviral vector-engineered stem cells.Dendritic cells and tumor microenvironment: a dangerous liaisonCan leukemia-derived dendritic cells generate antileukemia immunity?Dendritic cell biology during malaria.Harnessing the immune system to treat cancer.DC-based cancer vaccines.Regulatory T cells--the renaissance of the suppressor T cells.Rebuilding immunity in cancer patients.Sensors of ionizing radiation effects on the immunological microenvironment of cancer.KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity.
P2860
Q24676809-7BBEFA56-4924-4838-BB3A-B929C7373C0EQ24684280-D0909F0A-657D-4EC6-9103-A89AF2E5A575Q26740647-9A993BFB-3A92-4DFA-91D7-ED0B9FA1B2C5Q27310303-ACCCE410-A7D7-4D22-B3A0-50E9EEDD89DCQ29619244-45AF4AED-6470-4AAE-B32B-D167BD684D90Q29636247-DFE212F9-4049-4A74-9E1E-39A24665C4E1Q31022597-86FB9C31-D252-469E-AB85-BC624B9BD8F1Q33618936-CF15C823-A7ED-441F-AAB2-E9380A45D119Q33746583-1F9E3C71-199D-416F-B259-35BB11CD4844Q33951651-2AD2AE72-AEF9-45CD-B4BF-334D8C257F1FQ34122445-F223884E-DDA4-4BB1-94FD-951A00C36B16Q34185497-F1AF78E3-C284-4363-AEEA-DA42A78EF2CFQ34528054-F318F501-E276-4F98-87F6-3DB0C3A1958BQ35021619-487BEA92-CCCE-4E62-ADB1-3B942DF9204DQ35085385-86B5CFA2-F57A-431A-9C8A-DF7288E13EEBQ35399334-B5138A6B-1523-44ED-BA60-B2880A06EFEAQ35556913-ECFDBE19-804C-44FE-B8BE-FF6AD04C931AQ35684967-72A8A193-7FB5-47EE-A1D1-0AE297AE9199Q35793849-F4344A66-63B6-4FB9-80CD-EA4E20F31137Q35827348-CABDEDD8-79CD-48AA-B363-499F13F5388BQ35963926-F565ECE0-D7FB-4027-AC35-A8E465329DFBQ35999881-70820952-A5D9-4788-A7E6-4E3BE1E76609Q36075296-DE0DB302-97D3-42BD-900B-E101F48DEA30Q36108241-11D4B60F-195B-44A4-9BB7-9F47264D7013Q36140598-49091679-050C-4C7C-ACC2-137876730E81Q36150517-64332A7B-63FD-4E69-BB9A-CC3508206A6CQ36193536-0EE53C42-9860-47E9-B454-E67D1B2BD70FQ36204803-F4221187-84BE-492B-9E80-23E0D3484F9BQ36274581-45ECEBE2-DC6A-4E7D-9A55-F8BC03633872Q36367898-8CD5DDA4-F1DB-4A29-990C-F31EC7409FE7Q36482614-DE5EA132-4987-47B6-88DD-2854CD9AB84BQ36569018-043176F1-4623-4611-A1C2-EC032775B3CDQ36600332-2A3E5817-2131-4846-8412-F6313A3BC1F2Q36705307-305C9E5F-5E2B-4510-A9FE-2336D09864FAQ36809755-627CC4A6-4C65-46F2-96F3-BD8E79DB238BQ36809780-1A7E7904-DF87-445D-A3BB-8815AAA3E0DBQ36911411-91EBC6E5-D09A-4A00-96B9-93D88CA30B81Q36934947-D83BE6C4-89DE-4917-AA15-B254232E5C83Q36939594-558EA267-17DE-4841-A79D-61E856967AADQ36964813-62318CAD-3016-4807-B7F4-0A9130EABDC9
P2860
Manipulating dendritic cell biology for the active immunotherapy of cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Manipulating dendritic cell biology for the active immunotherapy of cancer.
@ast
Manipulating dendritic cell biology for the active immunotherapy of cancer.
@en
type
label
Manipulating dendritic cell biology for the active immunotherapy of cancer.
@ast
Manipulating dendritic cell biology for the active immunotherapy of cancer.
@en
prefLabel
Manipulating dendritic cell biology for the active immunotherapy of cancer.
@ast
Manipulating dendritic cell biology for the active immunotherapy of cancer.
@en
P1433
P1476
Manipulating dendritic cell biology for the active immunotherapy of cancer.
@en
P2093
David W O'Neill
Nina Bhardwaj
P304
P356
10.1182/BLOOD-2003-12-4392
P407
P50
P577
2004-07-01T00:00:00Z